logo dark logo light logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
logo dark logo light logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
Mobile Logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
Image Alt
News & Media

Phoenix

Mar 26
Phoenix
News

PHOENIX @ BNN newsletter (March 2021)

PHOENIX was introduced in the 50th BNN newsletter on the pages 26-27!

READ now
Like
PHOENIX @ BNN Networking event
March 10, 2021
PHOENIX @ InterNanoPoland
April 22, 2021

Related Posts

Mar 28
Phoenix

Women Behind PHOENIX: Alba Córdoba Insensé

Read More
Mar 23
Phoenix

Women Behind PHOENIX: Angela Fernandez-Otal

Read More
Mar 21
Phoenix

Women Behind PHOENIX: Elisabet González Mira

Read More

Post Categories

  • Events
  • News
  • Newsletter
  • Project Outcomes

Recent News

  • PHOENIX Newsletters March 30, 2023
  • Women Behind PHOENIX: Alba Córdoba Insensé March 28, 2023
  • Women Behind PHOENIX: Angela Fernandez-Otal March 23, 2023

Tags

call nanopharmaceuticals

Contact us

MyBiotech GmbH
Industriestraße 1B
66802 Überherrn
Germany
info@phoenix-oitb.eu

Join the PHOENIX community!

Our latest tweets

Retweet on TwitterPHOENIX OITB Retweeted
Avatarnano2clinic@nano2clinic·
30 Mar

Dear COSTers,
the program and the presentations offered at our CA17140 Stakeholder event held in Zagreb on March 3, 2023 are available on our deedicated website page at:
... https://www.nano2clinic.eu/stakeholder-one-day-event-nano2clinic-synergies-clinical-translation-nanotechnology-cancer

AvatarPHOENIX OITB@phoenixoitb·
30 Mar

The @phoenixoitb consortium met online to discuss the progress at month 24. We are reviewing open call applications and shared progress of our demo cases 😊.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 953110.

  • Downloads
  • Legal Notice
  • Privacy Policy